Data Collective IV GP, LLC Long-Term Concentrated

CIK: 0001664974 · Show all filings

Period: Q2 2024 (← Previous) (Next →)

Filing Date: Aug 14, 2024

Total Value ($000): $142,690 (100.0% shares, 0.0% debt)

Holdings (6)

OKLO Oklo Inc. 41.1%

Value ($000) $58,619 Shares 6,920,804 Est. Cost $11.25 Unrealized 0.0%

RXRX Recursion Pharmaceuticals, Inc. 31.2%

Value ($000) $44,558 Shares 5,941,120 Est. Cost $18.82 Unrealized -53.6%

EVLV Evolv Technologies Holdings, Inc. 17.3%

Value ($000) $24,687 Shares 9,681,281 Est. Cost $5.61 Unrealized -41.0%

— Rocket Lab USA, Inc. 9.9%

Value ($000) $14,061 Shares 2,929,350 Est. Cost $4.04 Unrealized —

— Mind Medicine (MindMed) Inc. 0.5%

Value ($000) $724 Shares 100,350 Est. Cost $3.17 Unrealized —

ROIV Roivant Sciences Ltd. 0.0%

Value ($000) $41 Shares 3,875 Est. Cost $5.56 Unrealized +97.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
OKLO	Oklo Inc.	6,920,804	$58,619	41.1%	$11.25	0.0%	COM CL A	02156V109
RXRX	Recursion Pharmaceuticals, Inc.	5,941,120	$44,558	31.2%	$18.82	-53.6%	CL A	75629V104
EVLV	Evolv Technologies Holdings, Inc.	9,681,281	$24,687	17.3%	$5.61	-41.0%	COM CL A	30049H102
—	Rocket Lab USA, Inc.	2,929,350	$14,061	9.9%	$4.04	—	COM	773122106
—	Mind Medicine (MindMed) Inc.	100,350	$724	0.5%	$3.17	—	COM NEW	60255C885
ROIV	Roivant Sciences Ltd.	3,875	$41	0.0%	$5.56	+97.0%	SHS	G76279101